✦ LIBER ✦

Atypical epithelial hyperplasia associated with breast cancer and fibrocystic disease

✍ Scribed by William H. Kern; Robert N. Brooks

Publisher: John Wiley and Sons
Year: 1969
Tongue: English
Weight: 822 KB
Volume: 24
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(196910)24:4<668::aid-cncr2820240403>3.0.co;2-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast cancer risk associated with proli

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia

✍ William D. Dupont; Fritz F. Parl; William H. Hartmann; Louise A. Brinton; Alan C 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 754 KB

Background. Women with proliferative breast disease (PD) have been observed to have an increased risk of breast cancer. The authors evaluated the effect of PD on breast cancer risk in a case-control study among participants of the Breast Cancer Detection Demonstration Project (BCDDP). Methods. More

Breast cancer risk associated with estro

Breast cancer risk associated with estrogen receptor expression in epithelial hyperplasia lacking atypia and adjacent lobular units

✍ Helenice Gobbi; William D. Dupont; Fritz F. Parl; Peggy A. Schuyler; W. Dale Plu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 144 KB

## Abstract Estrogen is associated with many epidemiologic risk factors for invasive breast cancer. Cells that express estrogen receptors (ERs) in epithelial hyperplasia lacking atypia (EHLA) may influence breast cancer progression. We conducted a nested case‐control study of 268 women with biopsy‐

The genes for gonadotropin-releasing hor

The genes for gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic disease and cancer

✍ Marie-Laure Kottler; Anna Starzec; Marie-Claude Carre; Jean-Pierre Lagarde; Anto 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 100 KB 👁 2 views

While gonadotropin-releasing hormone (GnRH) or GnRH receptor (GnRHR) have been reported to exist in tissues other than brain and pituitary, there is no report concerning co-expression of GnRH and GnRHR in human breast tissues. To address this question, we have examined whether mRNA for GnRH as well

Cytokeratin expression in breast cancer:

Cytokeratin expression in breast cancer: Phenotypic changes associated with disease progression

✍ I. Brotherick; C. N. Robson; D. A. Browell; J. Shenfine; M. D. White; W. J. Cunl 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Transition from a normal to a cancerous state is marked by alterations in the cytoskeletal structure of those cells involved. We have examined such changes to determine if these transitions are markers of disease progression. Cytokeratin (CK) protein and messenger RNA (mRNA) expression were examined